REQUEST A DEMO
Total
USD $0.00
Search more companies

R&G Pharmastudies Co.,Ltd (China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: R&G Pharmastudies Co.,Ltd Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

R&g Pharmastudies Co.,Ltd. is a professional clinical trial outsourcing service provider, (clinical cro enterprise), which provides comprehensive clinical research and development process integrated services for global pharmaceutical enterprises and scientific research institutions. The main services of the company cover all stages of pharmaceutical clinical research, including clinical trial operation services ("co services"), clinical trial site management services ("SMO services"), biological sample testing services ("Ba services"), data management and statistical analysis services ("DM /st services"), clinical trial consulting services, clinical pharmacology services ("CP services"), etc. The company was established in 2008 and is headquartered in Beijing City, China.

Headquarters
11th Floor, North Tower, Block B, Huatong Building, No. 19 Chegongzhuang West Road, Haidian District, Beijing
Beijing; Beijing; Postal Code: 100048

Contact Details: Purchase the R&G Pharmastudies Co.,Ltd report to view the information.

Website: http://www.rg-pharma.com

Basic Information
Total Employees:
Purchase the R&G Pharmastudies Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the R&G Pharmastudies Co.,Ltd report to view the information.
Registered Capital:
Purchase the R&G Pharmastudies Co.,Ltd report to view the information.
Financial Auditors:
Purchase the R&G Pharmastudies Co.,Ltd report to view the information.
Incorporation Date:
August 22, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
28.68%
Purchase this report to view the information.
12.23%
Purchase this report to view the information.
12%
Purchase this report to view the information.
7.13%
Purchase this report to view the information.
5%
Subsidiaries
Beijing Lingchu Pharmaceutical Technology Co., Ltd.
Beijing Nuohe Management Consulting Co., Ltd
Hefei Ecoman Medical Technology Co., Ltd.
Company Performance
Financial values in the chart are available after R&G Pharmastudies Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
7.1%
Total operating revenue
6.58%
Operating profit (EBIT)
-31.96%
Net Profit (Loss) for the Period
-31.99%
Total assets
14.21%
Total equity
4.9%
Operating Profit Margin (ROS)
-9.95%
Net Profit Margin
-8.78%
Return on Equity (ROE)
-2.61%
Quick Ratio
-1.67%
Cash Ratio
-1.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?